Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03054376
What this trial is testing

Vascular Health With Immobilization and Exercise Training

Who this might be right for
Immobilization, TonicPhysical Activity
University of Copenhagen 12
Not applicableUnknownNCT01148407
What this trial is testing

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Who this might be right for
Cancer
University of Vermont 30
Not applicableUnknownNCT00145262
What this trial is testing

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Who this might be right for
Buerger DiseaseArteriosclerosis Obliterans
Nagoya University
Not applicableStudy completedNCT05688046
What this trial is testing

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

Who this might be right for
NSCLC
Suzhou Municipal Hospital 79
Large-scale testing (Phase 3)UnknownNCT02350361
What this trial is testing

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Who this might be right for
Lung Cancer
Peking University Third Hospital 60
Large-scale testing (Phase 3)Study completedNCT00334282
What this trial is testing

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 435
Not applicableNot Yet RecruitingNCT07570368
What this trial is testing

Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasm FemaleLocally Advanced Breast Cancer (LABC)+1 more
Universitas Airlangga 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06537505
What this trial is testing

Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

Who this might be right for
Solid Tumor
Beidahuang Industry Group General Hospital 60
Not applicableStudy completedNCT00994370
What this trial is testing

Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 36
Testing effectiveness (Phase 2)Study completedNCT06562673
What this trial is testing

Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma

Who this might be right for
OsteosarcomaBone Cancer
Shanghai 6th People's Hospital 10
Not applicableUnknownNCT04523467
What this trial is testing

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320
Early research (Phase 1)Study completedNCT00861419
What this trial is testing

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Who this might be right for
Advanced Solid Tumors
Amgen 88
Testing effectiveness (Phase 2)Study completedNCT00744536
What this trial is testing

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicAngiogenesis
Sunnybrook Health Sciences Centre 20
Testing effectiveness (Phase 2)Ended earlyNCT00369395
What this trial is testing

Volociximab in Metastatic Melanoma

Who this might be right for
Stage IV Melanoma
Abbott 19
Not applicableStudy completedNCT06644521
What this trial is testing

Angiogenic Factors in the Placentas of Women With COVID-19

Who this might be right for
COVID-19Placenta DiseasesAngiogenesis
Manisa Celal Bayar University 40
Large-scale testing (Phase 3)Study completedNCT00826683
What this trial is testing

Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung CancerChronic Obstructive Pulmonary Disease
University Hospital, Limoges 140
Testing effectiveness (Phase 2)Study completedNCT04877821
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC

Who this might be right for
Triple Negative Breast Cancer
Guangdong Provincial People's Hospital 29
Not applicableStudy completedNCT04541316
What this trial is testing

Neo-angiogenesis in Inguinal Henia Implant ProFlor

Who this might be right for
Inguinal Hernia
University of Cagliari 15
Early research (Phase 1)Study completedNCT01120288
What this trial is testing

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Who this might be right for
NeoplasmsLiver Metastases
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Study completedNCT00056459
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis 1,168
Next Page